Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Poc Hba1C Testing Market Through 2034?

The size of the poc hba1c testing market has witnessed significant expansion in the last few years. It is forecasted to swell from $0.92 billion in 2024 to $1.02 billion in 2025, representing a compound annual growth rate (CAGR) of 10.6%. This substantial growth in the past years draws its roots from a robust economic upturn in developing markets, a hike in the occurrence of diabetes, an escalation in COVID-19 cases, and a rise in disposable income.

The point of care (POC) Hba1c testing market is predicted to experience considerable growth in the forthcoming years, expanding to a value of $1.59 billion in 2029, boasting a compound annual growth rate (CAGR) of 11.7%. The projected growth in the coming period can be credited to factors such as increased government backing, a rising frequency of type II diabetes, the convenience of POC tests, and quicker results when compared with traditional lab testing methods. Key trends expected to shape the forecast period involve focussing on Hba1c microfluidic immunofluorescence testing, surging usage of residential Hba1c testing kits, emphasis on Hba1c testing via capillary electrophoresis technology, and advancements in testing technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6833&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Poc Hba1C Testing Market?

The surge in diabetes occurrences is predicted to boost the expansion of the POC HbA1C testing market. The rising prevalence of diabetes is largely attributed to long work hours, insufficient physical exercise, and unhealthy dietary and drinking habits. Diabetes diagnosis and monitoring can be carried out using point-of-care (POC) HbA1c assays, which are applicable in community environments and healthcare institutions even without labs. As reported by the UK’s National Health Service (NHS) in June 2024, there has been a notable increase in the number of individuals under 40 living with diabetes, rising from 173,166 in 2022 to 216,440 in 2023. This substantial growth underscores a worrisome trend in this demographic. The statistics demonstrate a swift surge in diabetes occurrences among the young generation. Consequently, the escalating cases of diabetes are fueling the expansion of the POC hba1c testing market.

Which Key Market Segments Comprise the Poc Hba1C Testing Market and Drive Its Revenue Growth?

The poc hba1c testingmarket covered in this report is segmented –

1) By Type of Product: Instruments, Consumables

2) By Technology: Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Immunoassay, Other Technologies

3) By End User: Hospitals, Physician Office Or Outpatient Center, Home Care, Other End Users

Subsegments:

1) By Instruments: Handheld HbA1c Testing Devices, Portable HbA1c Analyzers, Desktop HbA1c Testing Systems, Integrated Point Of Care Testing Systems

2) By Consumables: Test Strips, Control Solutions, Reagents, Calibration Solutions, Sample Collection Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6833&type=smp

Which Areas Are Leading Regions in the Poc Hba1C Testing Market Expansion Across the Globe?

North America was the largest region in the POC HbA1C testing market in 2024. Africa is expected to be the fastest-growing region in the forecast- period. The regions covered in the POC hba1c testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in thePoc Hba1C Testing Market Over the Coming Years?

A prominent trend in the POC HbA1C testing market is the progressive adoption of technological advances. Existing dominant players in the market are concentrating on the development of cutting-edge technologies to deliver accurate and rapid results, thus assisting labs in handling the growing testing needs. For example, Abbott, an American healthcare and medical devices firm, has launched Afinion HbA1c Dx assay. This in vitro diagnostic test quantitively determines HbA1c in human venous and capillary blood and can be used on the Afinion 2 Analyzer as well as the Afinion AS100 Analyzer. Remarkably, the Afinion HbA1c Dx assay is the solitary rapid POC test approved by the U.S. FDA for aiding health professionals in diagnosing diabetes and assessing a patient’s risk for the disease. Delivering reliable and accurate 1,2 glycated hemoglobin readings in merely three minutes, this test facilitates physicians in assessing patients and formulating personalized treatment plans during a single appointment.

View the full report here:

https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report

How Is the Poc Hba1C Testing Market Conceptually Defined?

POC HbA1C testing devices are designed to diagnose average levels of glucose in patients’ blood and to control type I and type II diabetes mellitus. Diabetes is a chronic disease that occurs either when an inadequate amount of insulin is produced by the pancreas or when the body cannot use the insulin it produces effectively. This assesses the average level of blood sugar over 2 to 3 months in an individual.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6833

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model